Literature DB >> 19730792

Studies on the neuroprotective role of Piper longum in C6 glioma induced rats.

Umadevi Subramanian1, Sharmila Poongavanam, A J Vanisree.   

Abstract

Many naturally occurring substances of plant origin ingested in human diet, exhibit anticarcinogenic and antimutagenic effects. One of the active phytochemical which shows the active anticarcinogenic role is Piper longum Linn. (Pl). Pl is widely used in ayurvedic industry due to its property in healing some of the bodily ailments. Despite being known for the antioxidant, antimicrobial and anticarcinogenic effects, its relation to brain and its tumour development is still scarce. Hence, the experimental glioma model was developed in rats using C6 glioma cells and the effect of Pl was evaluated in the brain tissue of experimental group of rats. From the study, the glioma induced animals showed an increased level of lipid peroxides (LPO), tissue marker enzymes lactate dehydrogenase (LDH), creatine kinase (CK), 5'nucleotidase (5'ND) and acetylcholine esterase (AChE). But Pl treatment (20 mg/kg body weight) significantly attenuated these alterations thereby showing potent anticancer effect in glioma induced rats. In addition, the anticarcinogenic effect of Pl was confirmed by microscopic analysis and the restoration of increased lipids and protein bound carbohydrates (PBCs) in the brain tissue of glioma induced rats. Hence our results implicate a major role for Pl in preventing the cancer development in the experimental glioma model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19730792     DOI: 10.1007/s10637-009-9301-1

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  64 in total

1.  Hypercholesterolemia in rats with hepatomas: increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol.

Authors:  Takeshi Hirayama; Akira Honda; Yasushi Matsuzaki; Teruo Miyazaki; Tadashi Ikegami; Mikio Doy; Guorong Xu; Michael Lea; Gerald Salen
Journal:  Hepatology       Date:  2006-09       Impact factor: 17.425

2.  Anti-tumour potential of a gallic acid-containing phenolic fraction from Oenothera biennis.

Authors:  Chiara Dalla Pellegrina; Giorgia Padovani; Federica Mainente; Gianni Zoccatelli; Gaetano Bissoli; Silvia Mosconi; Gianluca Veneri; Angelo Peruffo; Giancarlo Andrighetto; Corrado Rizzi; Roberto Chignola
Journal:  Cancer Lett       Date:  2005-01-08       Impact factor: 8.679

3.  [Biochemical monitoring of postoperative glioma (author's transl)].

Authors:  M Hara; H Yokota; M Ogashiwa; K Takeuchi
Journal:  No To Shinkei       Date:  1981-05

4.  The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells.

Authors:  T Kodera; T Nakagawa; T Kubota; M Kabuto; K Sato; H Kobayashi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

5.  Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance.

Authors:  P Ujházy; E S Berleth; J M Pietkiewicz; H Kitano; J R Skaar; M J Ehrke; E Mihich
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

6.  Fast NMR evaluation of lipids in human tissues.

Authors:  Maria Raffaella Tosi; Andrea Trinchero; Alba Poerio; Vitaliano Tugnoli
Journal:  Ital J Biochem       Date:  2003-12

7.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

Review 8.  Kava: an overview.

Authors:  Y N Singh
Journal:  J Ethnopharmacol       Date:  1992-08       Impact factor: 4.360

9.  Lipids in blood-brain barrier models in vitro II: Influence of glial cells on lipid classes and lipid fatty acids.

Authors:  Stefanie D Krämer; Yannic B Schütz; Heidi Wunderli-Allenspach; N Joan Abbott; David J Begley
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Nov-Dec       Impact factor: 2.416

10.  Assisted dying and end-of-life symptom management.

Authors:  Deborah L Volker
Journal:  Cancer Nurs       Date:  2003-10       Impact factor: 2.592

View more
  5 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  6-Shogaol, an active compound of ginger, protects dopaminergic neurons in Parkinson's disease models via anti-neuroinflammation.

Authors:  Gunhyuk Park; Hyo Geun Kim; Mi Sun Ju; Sang Keun Ha; Yongkon Park; Sun Yeou Kim; Myung Sook Oh
Journal:  Acta Pharmacol Sin       Date:  2013-07-01       Impact factor: 6.150

3.  Effect of Naringenin on metabolic markers, lipid profile and expression of GFAP in C6 glioma cells implanted rat's brain.

Authors:  S Devan; V A Janardhanam
Journal:  Ann Neurosci       Date:  2011-10

Review 4.  Stroke medicine in antiquity: The Greek and Muslim contribution.

Authors:  Inam Khuda; Foziah Al-Shamrani
Journal:  J Family Community Med       Date:  2018 Sep-Dec

5.  XIAP as a Target of New Small Organic Natural Molecules Inducing Human Cancer Cell Death.

Authors:  Diego Muñoz; Martina Brucoli; Silvia Zecchini; Adrian Sandoval-Hernandez; Gonzalo Arboleda; Fabian Lopez-Vallejo; Wilman Delgado; Matteo Giovarelli; Marco Coazzoli; Elisabetta Catalani; Clara De Palma; Cristiana Perrotta; Luis Cuca; Emilio Clementi; Davide Cervia
Journal:  Cancers (Basel)       Date:  2019-09-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.